申请人:Graybug Vision, Inc.
公开号:US20170080092A1
公开(公告)日:2017-03-23
The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and other drugs, as well as controlled delivery formulations containing such prodrugs and derivatives, for the treatment of ocular disorders.
该披露描述了前药和前列腺素的衍生物、碳酸酐酶抑制剂、激酶抑制剂、β-肾上腺素受体拮抗剂和其他药物,以及含有这些前药和衍生物的受控释放配方,用于治疗眼部疾病。